Goldman Sachs’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,775
| Closed | -$208K | – | 5333 |
|
|
2025
Q1 | $208K | Sell |
15,775
-11,750
| -43% | -$155K | ﹤0.01% | 4667 |
|
|
2024
Q4 | $493K | Buy |
27,525
+16,189
| +143% | +$290K | ﹤0.01% | 4306 |
|
|
2024
Q3 | $183K | Buy |
+11,336
| New | +$183K | ﹤0.01% | 4519 |
|
|
2024
Q2 | – | Sell |
-39,335
| Closed | -$23M | – | 4886 |
|
|
2024
Q1 | $23M | Sell |
39,335
-10,232
| -21% | -$5.99M | ﹤0.01% | 1444 |
|
|
2023
Q4 | $1.03M | Buy |
49,567
+4,958
| +11% | +$103K | ﹤0.01% | 3602 |
|
|
2023
Q3 | $1.42M | Sell |
44,609
-2,420
| -5% | -$77K | ﹤0.01% | 3307 |
|
|
2023
Q2 | $1.58M | Buy |
47,029
+34,172
| +266% | +$1.15M | ﹤0.01% | 3345 |
|
|
2023
Q1 | $536K | Buy |
12,857
+10,252
| +394% | +$428K | ﹤0.01% | 4033 |
|
|
2022
Q4 | $88.3K | Sell |
2,605
-2,396
| -48% | -$81.2K | ﹤0.01% | 4701 |
|
|
2022
Q3 | $246K | Sell |
5,001
-3,755
| -43% | -$185K | ﹤0.01% | 4633 |
|
|
2022
Q2 | $344K | Sell |
8,756
-29,886
| -77% | -$1.17M | ﹤0.01% | 4612 |
|
|
2022
Q1 | $1.43M | Sell |
38,642
-2,235
| -5% | -$82.5K | ﹤0.01% | 3847 |
|
|
2021
Q4 | $4M | Sell |
40,877
-2,334
| -5% | -$228K | ﹤0.01% | 2981 |
|
|
2021
Q3 | $5.39M | Sell |
43,211
-10,600
| -20% | -$1.32M | ﹤0.01% | 2739 |
|
|
2021
Q2 | $6.75M | Sell |
53,811
-17,060
| -24% | -$2.14M | ﹤0.01% | 2565 |
|
|
2021
Q1 | $9.62M | Buy |
70,871
+51,185
| +260% | +$6.95M | ﹤0.01% | 2231 |
|
|
2020
Q4 | $1.79M | Buy |
19,686
+13,135
| +201% | +$1.19M | ﹤0.01% | 3136 |
|
|
2020
Q3 | $487K | Buy |
6,551
+4,668
| +248% | +$347K | ﹤0.01% | 3682 |
|
|
2020
Q2 | $160K | Sell |
1,883
-1,294
| -41% | -$110K | ﹤0.01% | 4061 |
|
|
2020
Q1 | $230K | Buy |
3,177
+2,587
| +438% | +$187K | ﹤0.01% | 3887 |
|
|
2019
Q4 | $42K | Sell |
590
-235
| -28% | -$16.7K | ﹤0.01% | 4212 |
|
|
2019
Q3 | $43K | Buy |
825
+116
| +16% | +$6.05K | ﹤0.01% | 4144 |
|
|
2019
Q2 | $38K | Sell |
709
-24
| -3% | -$1.29K | ﹤0.01% | 4103 |
|
|
2019
Q1 | $52K | Sell |
733
-283
| -28% | -$20.1K | ﹤0.01% | 4083 |
|
|
2018
Q4 | $81K | Buy |
1,016
+202
| +25% | +$16.1K | ﹤0.01% | 3921 |
|
|
2018
Q3 | $380K | Buy |
814
+201
| +33% | +$93.8K | ﹤0.01% | 3560 |
|
|
2018
Q2 | $244K | Buy |
613
+243
| +66% | +$96.7K | ﹤0.01% | 3805 |
|
|
2018
Q1 | $113K | Sell |
370
-612
| -62% | -$187K | ﹤0.01% | 3994 |
|
|
2017
Q4 | $289K | Buy |
+982
| New | +$289K | ﹤0.01% | 3671 |
|
|
2017
Q2 | – | Sell |
-1,053
| Closed | -$452K | – | 4503 |
|
|
2017
Q1 | $452K | Buy |
1,053
+478
| +83% | +$205K | ﹤0.01% | 3564 |
|
|
2016
Q4 | $296K | Sell |
575
-1,234
| -68% | -$635K | ﹤0.01% | 3720 |
|
|
2016
Q3 | $773K | Buy |
1,809
+976
| +117% | +$417K | ﹤0.01% | 3190 |
|
|
2016
Q2 | $350K | Buy |
+833
| New | +$350K | ﹤0.01% | 3551 |
|